Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)

PHASE3CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Uterine Cervical Neoplasms
Interventions
DRUG

chemotherapy: Paclitaxel/Cisplatin

Drug: chemotherapy: Paclitaxel/Cisplatin

DRUG

chemotherapy: Paclitaxel/Carboplatin

Drug: chemotherapy: Paclitaxel/Carboplatin

Trial Locations (30)

464-8681

Aichi Cancer Center Hospital, Nagoya,Chikusa-ku,Kanokoden,1-1

460-0001

Nagoya Medical Center, Nagoya,Naka-ku,Sannomaru,4-1-1

790-0007

National Hospital Organization Shikoku Cancer Center, Matsuyama,Horinouchi,13

812-8582

Kyushu University Hospital, Fukuoka,Higashi-ku,Maidashi,3-1-1

811-1395

National Kyushu Cancer Center, Fukuoka,Minami-ku,Notame,3-1-1

830-0011

Kurume University School of Medicine, Kurume, Asahi-machi, 67

373-8550

Gunma Prefectural Cancer Center, Ota,Takabayashi-nishi-cho,617-1

737-0023

National Hospital Organization Kure Medical Center Chugoku Cancer Center, Kure,Aoyama-cho,3-1

060-8648

Hokkaido University Hospital, North-14 West-5 Kita-ku,Sapporo

060-8543

Sapporo Medical University, S-1,W-16,Chuo-ku,Sapporo

673-8558

Hyogo Medical Center for Adults, Akashi,Kitaouji-cho,13-70

305-8575

Institute of Clinical Medicine,Tsukuba University Hospital, Tsukuba,Tennodai,1-1-1

892-8580

Kagoshima City Hospital, Kagoshima,Kajiya-cho,20-17

980-8574

Tohoku University Hospital, Sendai,Aoba-ku,Seiryo-machi,1-1

390-8621

Sinshu University, Matsumoto,Asahi,3-1-1

940-2085

Nagaoka Red Cross Hospital, Nagaoka,Terashima-cho,297-1

951-8566

Niigata Cancer Center Hospital, Niigata,Kawagishi-cho,2-15-3

537-8511

Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka,Higashinari-ku,Nakamichi,1-3-3

534-0021

Osaka City General Hospital, Osaka,Miyakojima-ku,Miyakojimahondori,2-13-22

589-8511

Kinki University School of Medicine, Osaka-Sayama,Ohno-higashi,377-2

849-8501

Faculty of Medicine, Saga University, Saga,Nabeshima,5-1-1

350-8550

Saitama Medical Center, Saitama Medical School, Kawagoe,Komoda,1981

362-0806

Saitama Cancer Center, Kita-adachi,Ina,Komuro,818

359-8513

National Defense Medical College, Tokorozawa,Namiki,3-2

113-0033

Juntendo University School of Medicine, Bunkyo-ku,Hongo,3-1-3

113-8655

The University of Tokyo Hospital, Bunkyo-ku,Hongo,7-3-1

104-0045

National Cancer Center Hospital, Chuo-ku,Tsukiji,5-1-1

135-8550

Cancer Institute Hospital, Koto-ku,Ariake,3-10-6

105-8461

Jikei University Hospital, Minato-ku,Nishishinbashi,3-25-8

683-8504

Tottori University School of Medicine, Yonago,Nishimachi,36-1

All Listed Sponsors
collaborator

Ministry of Health, Labour and Welfare, Japan

OTHER_GOV

lead

Haruhiko Fukuda

OTHER

NCT00295789 - Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3) | Biotech Hunter | Biotech Hunter